President & CEO of Cidara Therapeutics.
San Diego, CA
Joined January 2010
- Tweets730
- Following372
- Followers1.2K
- Likes693
Jeff Stein retweeted
By spinning clinical flu program back out from partner JNJ into itself, Cidara has renewed purpose & becomes first fledgling to take flight from RA Capital’s Project Condor.
What’s Condor? More on that, the Cidara deal, & other things w/ bird names & big plans here…
rapport.bio/all-stories/rave… – at Fraser-Fort George H, British Columbia
Jeff Stein retweeted
Many thanks to Authority Magazine for the comprehensive coverage of @LS_Cares @LS_CaresPhilly @LS_CaresSD @LS_CaresBayArea @LS_CaresNY #CareActively medium.com/authority-magazin…
Jeff Stein retweeted
Hasan on attitude, Giannis, and buying your first NBA jersey. This is beautiful. @hasanminhaj
Missing the 4th C: Cost which drives prescribing decisions often to the detriment of the patient. Reimbursement reform offered by #DISARM Act can enable physicians to prescribe the most effective instead of the cheapest drug
I’d like to paraphrase this, with appropriate attribution to the Kahn of course, and assign its power to my Chief Business Officer.
Jeff Stein retweeted
Please join us for the @CidaraThera Research and Development Day featuring Key Oncology Opinion Leaders Dr. Ezra Cohen and Dr. Perry Nisen, and Cidara Chief Scientific Officer Dr. Les Tari. Register here: lifesci.events/CDTX
IDK but Mission Bay and Longfellow appear a bit low energy compared to the rest of the crew pictures.
Jeff Stein retweeted
A terrific read from @PeterKolchinsky
👏🏽
Soothing, actually!
Biotech’s Dulcius Ex Asperis: The Way Through This Downturn — RApport rapport.bio/all-stories/the-…
Jeff Stein retweeted
of the first drug, CTI-005, Human Red Blood Cell Nanosponges, for patients hospitalized with Staphylococcus aureus pneumonia. Additional Cellics technologies now in the pipeline targeting sepsis with support of @CARB_X and studied in our labs @UCSanDiego
finance.yahoo.com/news/celli… – at San Diego, CA
Jeff Stein retweeted
The first cohort of healthy volunteers has been dosed in Cidara's Phase 1 trial of CD388, a highly potent long-acting antiviral immunotherapy designed to deliver universal prevention of seasonal and pandemic #influenza. bit.ly/3wRMjtX $CDTX
I’ve never had as much interest in the “Russian” side and all my life when asked about it I’ve always responded “Russian/Jewish and Japanese”. Here forward I will proudly respond “Ukrainian/Jewish and Japanese”.
My grandparents on my father’s side were from Kyiv and emigrated to the US in the 1920’s when Ukraine was transitioning to “Russia”. On my mother’s side I am Japanese and have largely identified with her side of my heritage.
So proud and impressed by this incredible accomplishment by $CDTX board member Bonnie Bassler .@WolfPrize_
Jeff Stein retweeted
Older adults are at higher risk for contracting the flu, even if vaccinated. Cidara & @JNJNews are developing CD388, a new antiviral preventive therapy, to deliver universal protection for an entire flu season, even among higher-risk individuals bit.ly/354j9vZ $CDTX $JNJ
Jeff Stein retweeted
Pleased to see the Biden administration supporting #AMR legislation. The #PASTEURAct is one potential pull incentive; we must work together to fix reimbursement. Complementary reimbursement reform legislation proposed in the #DISARMAct is urgently needed. bit.ly/3H1fTzi
Hey @HardcoreHistory Dan Carlin, Professor @Prof_Malhotra Malhotra’s class at HBS is right up your alley.
Excited to announce the return & expansion of my @HarvardHBS course on "War & Peace: The Lessons of History for Strategy, Leadership, Negotiation, Policy & Humanity". Check out the game plan, & if you're an #MBA student (Class of 2022), I hope to see you in class next semester!
Jeff Stein retweeted
When I began my career in '80s, I practiced what is now called “antibiotic stewardship”– the right antibiotic to the right patient. But it was “patient stewardship.” We need to reform how best antibiotics are valued and reform how insurance pays for them.sandiegouniontribune.com/opi…
